Advertisement
Syngene International Ltd.
Healthcare
23 April, 2015
Biocon to sell 10% stake in IVFA-backed R&D arm Syngene through offer-for-sale
Biopharmaceutical major Biocon Ltd's research and development arm Syngene International Ltd has filed draft red herring prospectus (DRHP) with securities ......
Healthcare
01 April, 2015
Biocon's arm Syngene appoints Peter Bains as CEO
Syngene International, a subsidiary of biopharmaceutical major Biocon Ltd, has appointed Peter Bains as chief operating officer, as per a ......
Healthcare
23 January, 2015
Biocon plans IPO for IVFA-backed drug discovery services arm Syngene
Biocon Ltd is looking to offload up to 15 per cent in its research arm Syngene International, a firm in ......
Healthcare
18 September, 2014
India Value Fund buying 10% in Biocon's research arm Syngene for $62M
Mid-market buyout specialist private equity firm India Value Fund Advisors (IVFA) is picking 10 per cent stake in Syngene International ......
Premium
Healthcare
19 August, 2014
Biocon subsidiary Syngene International looking to raise over $50M
Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country's largest drug research and development ......
Advertisement
Recommended for you
Advertisement